High-frequency cannabis use rose among pregnant women in U.S. surveys

Increases in high-frequency cannabis use among pregnant women in the United States during 2010-2019 and 2021-2023.

Archives of women's mental health β€’ β€’ Highly Relevant
πŸ€–

AI Summary

This observational study examined trends in cannabis-use frequency among pregnant women in the United States using National Survey on Drug Use and Health data. It included 7,310 participants from 2010–2019 and 1,992 from 2021–2023. The primary outcome was the prevalence of high-frequency use, defined as use on at least 15 days in the past month, compared with low-to-moderate use.

From 2010 to 2019, high-frequency use rose from 1.15% to 3.43%, while low-to-moderate use remained stable. In 2021–2023, high-frequency use was more common than low-to-moderate use among pregnant women reporting cannabis use (4.31% versus 2.36%). The survey also found that 35% of those reporting high-frequency use said a healthcare professional had recommended it, compared with 15% reporting low-to-moderate use. These survey findings describe trends and self-reports; they cannot establish why use changed or whether a clinician actually recommended it. As an abstract-based summary, this study also cannot determine cannabis’s effects on pregnancy outcomes or establish cause and effect.

πŸ’‘ Key Findings

1
From 2010 to 2019, high-frequency cannabis use during pregnancy increased from 1.15% to 3.43%; low-to-moderate use remained statistically stable.
High
85%
2
In 2021–2023, high-frequency use was reported by 4.31% of pregnant women, compared with 2.36% reporting low-to-moderate use.
High
85%
3
Among pregnant women reporting cannabis use in 2021–2023, 35% of those with high-frequency use and 15% with low-to-moderate use reported a healthcare professional had recommended it.
High
85%

πŸ“„ Original Abstract

PURPOSE: Adverse outcomes associated with cannabis use in pregnancy are affected by frequency of maternal cannabis use. This study examines time trends in frequency of cannabis use among U.S. pregnant women. METHODS: This study used data from the National Survey on Drug Use and Health. Participants included pregnant women aged 18-44 from 2010 to 2019 (n = 7,310), and 2021-2023 (n = 1,992). A multinomial regression model assessed time trends in low-moderate versus high-frequency cannabis use (< 15 versus [Formula: see text]15 days in the past month) from 2010 to 2019, controlling for age, education level, income, marital status and race/ethnicity. From 2021 to 2023, we examined the prevalence of low-moderate versus high-frequency cannabis use and whether use was reported as "recommended by a healthcare professional". RESULTS: From 2010 to 2019, high-frequency cannabis use in pregnancy increased from 1.15% to 3.43% (adjusted odds ratio (aOR) for increase per year = 1.10, 95% CI = 1.02-1.18), while low-to-moderate frequency cannabis use remained stable (1.76% in 2010, 1.93% in 2019; aOR = 1.04, 95% CI = 0.97-1.10). From 2021 to 2023, over half of pregnant women who used cannabis reported high-frequency use (4.31% high, versus 2.36% low-moderate). From 2021 to 2023, 15% of pregnant women reporting low-moderate cannabis use, versus 35% with high-frequency use, reported that cannabis use was recommended by a healthcare professional. CONCLUSIONS: High-frequency cannabis use during pregnancy increased among U.S women while low to moderate use of cannabis in pregnancy remained stable. From 2021 to 2023, one-third of pregnant women who used cannabis frequently reported that their use was recommended by a healthcare professional.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.